George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 681.40
Bid: 682.40
Ask: 682.80
Change: -1.40 (-0.21%)
Spread: 0.40 (0.059%)
Open: 691.00
High: 692.60
Low: 680.40
Prev. Close: 682.80
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Securities - Price Adjustment

11 Dec 2015 08:52

RNS Number : 7669I
Standard Chartered PLC
11 December 2015
 



Standard Chartered PLC

11 December 2015

NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

Notice of adjustment of the Conversion Price of U.S.$2,000,000,000 Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (Rule 144A ISIN: US853254AT77; Regulation S ISIN: USG84228CE61) (the "Securities")

Please be advised that further to (i) its announcement dated 30 March 2015 in relation to the issuance of the Securities, and (ii) its announcement dated 3 November 2015, prospectus dated 18 November 2015, supplementary prospectus dated 1 December 2015 and announcement dated 11 December 2015 (the "Rights Issue Results Announcement"), all in relation to the 2 for 7 rights issue of 728,432,451 new Ordinary Shares at 465 pence each (the "Rights Issue"), Standard Chartered PLC has, in accordance with the terms and conditions of the Securities (the "Terms and Conditions"), given notice to the Securityholders that the Conversion Price per Ordinary Share in respect of the Securities has been adjusted in accordance with the Terms and Conditions (the "Adjustment"). The Adjustment became effective on 23 November 2015 (the "Effective Date"). Prior to the Effective Date, the Conversion Price per Ordinary Share was U.S.$11.424. The adjusted Conversion Price per Ordinary Share, computed in accordance with Condition 7(e)(iv) of the Terms of Conditions, is U.S.$10.865.

Capitalised terms not otherwise defined in this announcement shall have the meanings given to them in the Terms and Conditions.

For further information with respect to the adjustment of the Conversion Price of the Securities, please paste the following URL into the address bar of the browser:

http://www.rns-pdf.londonstockexchange.com/rns/7669I_-2015-12-11.pdf

For further information, please contact:

James Hopkinson, Head of Investor Relations +44 (0)20 7885 7151

Jon Tracey, Global Head of Communications +44 (0)20 7885 7613

Shaun Gamble, Director, Media Relations +44 (0)20 7885 5934

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement does not constitute an offer of any securities for sale.

The Securities and any ordinary shares which may be delivered upon conversion of the Securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act").

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement has been prepared solely for information purposes and is not an offer (or a solicitation of an offer) to buy or sell any securities in any jurisdiction.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTBBRTMBIBMIA
Date   Source Headline
12th Sep 20225:15 pmRNSDirector/PDMR Shareholding
9th Sep 20225:55 pmRNSTransaction in Own Shares
8th Sep 20226:04 pmRNSTransaction in Own Shares
7th Sep 20226:15 pmRNSTransaction in Own Shares
6th Sep 20225:45 pmRNSTotal Voting Rights
6th Sep 20225:40 pmRNSTransaction in Own Shares
5th Sep 20226:05 pmRNSTransaction in Own Shares
2nd Sep 20226:10 pmRNSTransaction in Own Shares
1st Sep 20226:00 pmRNSTransaction in Own Shares
31st Aug 20225:54 pmRNSTransaction in Own Shares
30th Aug 20225:50 pmRNSTransaction in Own Shares
26th Aug 20226:05 pmRNSTransaction in Own Shares
25th Aug 20225:45 pmRNSTransaction in Own Shares
24th Aug 20225:57 pmRNSTransaction in Own Shares
23rd Aug 20226:00 pmRNSTransaction in Own Shares
22nd Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20225:53 pmRNSTransaction in Own Shares
18th Aug 20225:47 pmRNSTransaction in Own Shares
17th Aug 20225:40 pmRNSTransaction in Own Shares
16th Aug 20225:50 pmRNSTransaction in Own Shares
15th Aug 20226:00 pmRNSTransaction in Own Shares
12th Aug 20225:50 pmRNSTransaction in Own Shares
11th Aug 20226:00 pmRNSTransaction in Own Shares
10th Aug 20225:45 pmRNSTransaction in Own Shares
10th Aug 20223:30 pmRNSHalf Year 2022 Pillar 3 Disclosures
9th Aug 20225:50 pmRNSTransaction in Own Shares
8th Aug 20226:05 pmRNSTransaction in Own Shares
5th Aug 20226:22 pmRNSTransaction in Own Shares
5th Aug 20227:00 amRNSIssuance of US$1.25bn Additional Tier 1 Securities
4th Aug 20226:10 pmRNSTransaction in Own Shares
4th Aug 20226:10 pmRNSHolding(s) in Company
4th Aug 20222:30 pmRNSTotal Voting Rights
3rd Aug 20226:05 pmRNSTransaction in Own Shares
2nd Aug 20226:00 pmRNSTransaction in Own Shares
1st Aug 20226:05 pmRNSChange of Joint-Broker
1st Aug 202211:45 amRNSDirectorate Changes
1st Aug 202211:30 amRNSShare Buy-Back
29th Jul 20222:50 pmRNSPublication of Supplementary Prospectus
29th Jul 20227:00 amRNSSCPLC Half Year Results 2022 - Part 2
29th Jul 20227:00 amRNSSCPLC Half Year Results 2022 - Part 1
29th Jul 20227:00 amRNSHalf Year Report 2022
15th Jul 202210:55 amRNSOverseas Regulatory Announcement
7th Jul 20222:10 pmRNSTotal Voting Rights
28th Jun 202212:50 pmRNSOverseas Regulatory Announcement
27th Jun 20223:00 pmRNSPublication of Final Terms
16th Jun 202211:50 amRNSPublication of a Prospectus
15th Jun 20225:00 pmRNSHolding(s) in Company
14th Jun 20221:00 pmRNSHolding(s) in Company
13th Jun 20228:00 amRNSFinancial Markets Investor Event
10th Jun 20227:30 amRNSSCPLC publishes resolvability disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.